These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31255579)
21. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Lee LJ; Viswanathan AN Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049 [TBL] [Abstract][Full Text] [Related]
22. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial. Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678 [TBL] [Abstract][Full Text] [Related]
23. Treatment for retropharyngeal metastatic undifferentiated squamous cell carcinoma from an unknown primary site: results of a prospective study with irradiation to nasopharyngeal mucosa plus bilateral neck. Du C; Ying H; Zhang Y; Huang Y; Zhai R; Hu C Oncotarget; 2017 Jun; 8(26):42372-42381. PubMed ID: 28418897 [TBL] [Abstract][Full Text] [Related]
25. CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: effectiveness and safety in 16 patients. Gao F; Li C; Gu Y; Huang J; Wu P Eur J Radiol; 2013 Feb; 82(2):e70-5. PubMed ID: 23040418 [TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival. Kim YJ; Kim JY; Kim Y; Lim YK; Jeong J; Jeong C; Kim M; Lim MC; Seo SS; Park SY Strahlenther Onkol; 2016 Dec; 192(12):922-930. PubMed ID: 27734106 [TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience. Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152 [TBL] [Abstract][Full Text] [Related]
28. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Reddy SP; Marks JE Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):797-802. PubMed ID: 9128954 [TBL] [Abstract][Full Text] [Related]
29. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763 [TBL] [Abstract][Full Text] [Related]
30. Ultrasound guided conformal brachytherapy of cervix cancer: survival, patterns of failure, and late complications. Narayan K; van Dyk S; Bernshaw D; Khaw P; Mileshkin L; Kondalsamy-Chennakesavan S J Gynecol Oncol; 2014 Jul; 25(3):206-13. PubMed ID: 25045433 [TBL] [Abstract][Full Text] [Related]
31. Interstitial brachytherapy of oral squamous cell carcinoma with ultrasound-guided iodine-125 radioactive seed implantation. Tian Q; Zhu HH; Li H Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1680-1685. PubMed ID: 29630112 [TBL] [Abstract][Full Text] [Related]
32. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer. Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933 [TBL] [Abstract][Full Text] [Related]
33. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Lindegaard JC; Fokdal LU; Nielsen SK; Juul-Christensen J; Tanderup K Acta Oncol; 2013 Oct; 52(7):1510-9. PubMed ID: 23962242 [TBL] [Abstract][Full Text] [Related]
34. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation. Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118 [TBL] [Abstract][Full Text] [Related]
35. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria. Snyder JE; Willett AB; Sun W; Kim Y Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074 [TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321 [TBL] [Abstract][Full Text] [Related]
37. CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy. Yao L; Jiang Y; Jiang P; Wang H; Meng N; Qu A; Tian S; Sun H; Liu C; Wang J; Zhang K Brachytherapy; 2015; 14(5):662-9. PubMed ID: 26138110 [TBL] [Abstract][Full Text] [Related]
38. Fibre-optic endoscope-guided three-dimensional high-dose-rate interstitial brachytherapy for residual nasopharyngeal carcinoma after conventional external beam radiotherapy. Zhang X; Wu N; Zhao Z; Han D; He M; Yang W; Cheng G J Contemp Brachytherapy; 2019 Jun; 11(3):243-249. PubMed ID: 31435431 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience. Patra NB; Goswami J; Basu S; Chatterjee K; Sarkar SK Brachytherapy; 2009; 8(2):248-254. PubMed ID: 19230791 [TBL] [Abstract][Full Text] [Related]
40. Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes. Laliscia C; Gadducci A; Fabrini MG; Barcellini A; Guerrieri ME; Parietti E; Ursino S; Morganti R; Cafaro I; Paiar F Oncol Res Treat; 2017; 40(11):697-701. PubMed ID: 29065399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]